I'm VERY familiar with the IND process - and knew the date/timing.
The KEY IS - IF the FDA does not request any further information - and the guy is IN ERROR as it's 30 CALENDAR DAYS on an IND "Straight approval" unless info is requested, which was the case with QNTA ?
NOT SURE - who he talked to but it's straight "30 days", PERIOD !
MY GUESS IS - the way the guy gave you a clean response and made sure he talked to the CEO is they "HAVE NOT" had any further FDA requests for info which means BY DEFAULT the IND can become EFFECTIVE/APPROVED LITERALLY AT ANY TIME NOW (the 30 days does not even apply - THAT is only from date of first submission!) and then they can PROCEED WITH CLINICAL TRIALS, DISTRIBUTION TO MD's under the IND PROTOCOL ETC = MEGA MEGA HUGE "Street cred" to this new company post merger !!!
April 13th was the "final data set submitted to FDA" for the MedoLife Rx "Scorpion venom serum" IND submission - so it can be FDA APPROVED LITERALLY ON ANY DAY and not "30 days" - that time line no longer even applies. Again - not sure where this spoke guy got his info ?
ELSE - they were in the PRE IND "voluntary consultation" (which is the SMART/WISE WAY TO SUBMIT AN IND!) that phase with the FDA per the April 13th PR - and then submitted "all final data the FDA has requested" at which point the 30 day CALENDAR DAY CLOCK would have commenced potentially - which means it could be as soon as Monday or Tues next week depending on when the FDA received their final package (lets guess April 15th for example) -
AT WHICH POINT "30 calendar days" = approx May 18th or 19th approx !
They are being SEC COMPLAINT IMO - they CAN NOT "tip" the date or it would be INSIDER TRADING INFO. They MUST "OFFICIAL PR IT" the instant they get that IND granted !!
THIS GOES BALLISTIC and I mean HUGE BALLISTIC when the word "FDA APPROVED IND" appear in an official PR IMO ! Like 100's of percent gainer kinda huge :)